Novartis considers selling ophthalmology, respiratory units to invest in cutting-edge medicines Ruchika Sharma17 Nov 2022 12:15 PM ISTAny sale of the ophthalmology and respiratory businesses is likely to begin in 2023, after the process for Sandoz is completed, the Bloomberg report...
Novartis to prioritise US market, unfazed by drug pricing pushback Ruchika Sharma25 Sept 2022 2:51 PM ISTNovartis aspire to "organically build its U.S. business to become a top-five player in the U.S. by 2027," it said in a statement.
Novartis plans to shut down Sandoz North Carolina plant by 2023 end Ruchika Sharma12 Sept 2022 12:24 PM ISTZurich: Pharmaceuticals company Novartis plans to close a Sandoz generics plant in Wilson, North Carolina, around the end of 2023, it said on...
Novartis Sandoz division to go independent Ruchika Sharma25 Aug 2022 2:33 PM ISTThe standalone Sandoz would be headquartered in Switzerland and listed on the SIX Swiss Exchange, with an American Depositary Receipt (ADR) program in...
Sandoz Supplemental Biologics License application accepted by US FDA for biosimilar Hyrimoz high concentration formulation Ruchika Sharma24 July 2022 10:00 AM ISTAdalimumab is a human immunoglobulin G1 (IgG(1)) monoclonal antibody targeting tumor necrosis factor alpha (TNF-a).
Novartis no longer expects earnings decline at under-review Sandoz unit Ruchika Sharma19 July 2022 12:41 PM ISTNew Delhi: Swiss drugmaker Novartis said earnings at its Sandoz unit, the maker of cheap generic drugs that might be put up for sale, would...
Novartis leaning toward spinoff of USD 25 billion generics arm: Bloomberg Ruchika Sharma3 July 2022 12:30 PM ISTNew Delhi: Novartis AG is leaning toward a spinoff of its generic-drug unit, as a challenging environment for leveraged buyouts makes a potential sale...
Novartis division Sandoz inaugurates facility in Maharashtra for oral cancer medicines Ruchika Sharma1 July 2022 1:30 PM ISTThe plant, which is spread over 32,000 square metres, would cater to the export markets, it added.
Novartis to sack up to 8000 jobs worldwide Ruchika Sharma29 Jun 2022 2:53 PM ISTNovartis said the new structure would be implemented over the next months.
Novartis division Sandoz application for proposed biosimilar Hyrimoz's high concentration formulation accepted by EMA Ruchika Sharma19 Jun 2022 11:30 AM ISTUpon approval, the Hyrimoz (100 mg/mL) citrate-free HCF would offer reduced injection volume and potentially decrease the number of injections...
Sandoz launches generic equivalent of AbbVie eyedrop Combigan in US Ruchika Sharma17 April 2022 10:15 AM IST"Fixed combinations of medicines to treat ocular hypertension can offer patients enhanced convenience, improved adherence, reduced exposure to...
Sandoz, Ares Genetics extends collaboration to drive cutting-edge digital solutions for antimicrobial resistance Ruchika Sharma7 April 2022 12:51 PM ISTBasel: Sandoz has announced the extension and expansion until January 31, 2025 of its strategic collaboration agreement with Ares Genetics, aimed at...
